Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHWSL.L Regulatory News (HWSL)

  • There is currently no data for HWSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value and Company Update

17 Dec 2019 17:02

RNS Number : 2268X
Hadrian's Wall Secured Invs.Ltd
17 December 2019
 

17 December 2019

 

Hadrian's Wall Secured Investments Limited

 

Net Asset Value and Company Update

 

Further to the announcement made by Hadrian's Wall Secured Investments Limited (the "Company") on 9 December 2019, the board of the Company (the "Board") announces that as at 31 October 2019 the unaudited cum-income net asset value per Ordinary Share, as adjusted for the changes to the provisions set out in this announcement, was 81.54 pence.

 

In arriving at this NAV per Ordinary Share the Board has also consulted with the Company's auditor in respect of those loans and the provisions against them referred to in this announcement.

 

The Board would also like to provide further information on the current position of Biomass Optimum Fuels Limited ("BOFL") and Biomass Premium Fuels Limited ("BPFL"), together with an update on the remainder of the portfolio, as set out below.

 

Update on BOFL and BPFL

 

The Board has asked the Investment Adviser, Hadrian's Wall Capital Limited (the "Investment Adviser"), to evaluate the possible recovery outcomes for BOFL and BPFL. Whilst the Investment Adviser believes there will be some recovery from the assets, including the wood pellet heating systems which have potentially attractive government renewable heat initiative income streams attaching to them, and is now working to achieve this, there are likely to be additional costs as part of this process. However, the Company on advice from the Investment Adviser, is maintaining its provision on BOFL and BPFL at £18.1 million in aggregate, as announced on 20 November 2019, an increase to the previous provision of £3.27 million included in the 30 September 2019 NAV, the increase being equivalent to 10.33 pence per Ordinary Share.

 

 

Update on the rest of the portfolio

 

The Company announced on 27 June 2019 that one of the Company's borrowers was in the process of undertaking an equity raise or company sale. This is progressing, and it is hoped that it will conclude in the first quarter of 2020, which should ensure full repayment of the loan at its face value of £13 million, plus accrued interest of approximately £1 million, together with an early repayment fee such that it repays at more than face value. The Investment Adviser believes it more likely than not that the equity raise or company sale will conclude in the anticipated timeframe but, in the event that it does not, it is possible that the borrower might request the Company to provide additional capital for working capital purposes. Given the inherent uncertainty connected with any company sale or fund raise, the IFRS 9 general loss reserve has been increased from £1.3 million to £2 million (the increase being equivalent to 0.49 pence per Ordinary Share). Whilst the indicated valuations of the portfolio company support a full recovery, and the timeframe appears achievable, the borrower has limited liquidity and consequently a delay in the capital raise could expose the Company to the risk of further material loss. The Board continues to monitor this situation closely given the significance of this loan in the overall position of the Company's loan portfolio.

 

It has been agreed with the borrower of a loan with a face value of £4.1 million to defer some interest payments due to cash flow issues arising from unexpected mechanical failure at its plant which caused lower productivity and income for the borrower in recent months. It is expected that the plant will be fully operational again in January 2020. However, the Company has increased the IFRS 9 general loss reserve for this asset by circa £470,000 to £600,000 (the increase being equivalent to 0.33 pence per Ordinary Share).

 

The remaining loans in the portfolio are performing as expected.

 

Nonetheless, reflecting a more prudent approach to provisioning given recent experiences with the assets detailed herein, the Board has made an additional provision of £2.89 million (being equivalent to 2.02 pence per Ordinary Share) to the Company's IFRS 9 general loss reserves. 

 

The Board is continuing its strategic review of the options available to it as announced on 9 December 2019, and anticipates being in a position to provide a further update in the New Year. This exercise will include a review of the ongoing role of Hadrian's Wall Capital Limited, with the overall objective of maximising Shareholder value.

 

The information contained within this announcement constitutes inside information. The person responsible for arranging for the release of this announcement on behalf of the Company is Hannah Girard of Praxis Fund Services Limited.

LEI: 213800ABN7VKMVNOLG14

 

Contact Details

 

David Warr (Chairman)

Telephone 01481 737600

 

Winterflood Investment Trusts (Corporate Broker)

Joe Winkley / Neil Morgan

Telephone 020 3100 0000

 

Forward-looking statements

 

This press release may contain forward-looking statements with respect to the Company's future financial performance and position. Such statements are based on current expectations, estimates and projections of the Company and information currently available to the Company. The Company cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. The Company accepts no obligation to update the statements contained in this press release, unless required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGGBAPUPBGQM
Date   Source Headline
27th May 20207:00 amRNSNet Asset Value(s)
11th May 202011:38 amRNSHolding(s) in Company
5th May 20204:15 pmRNSPortfolio Update
4th May 20209:24 amRNSNet Asset Value(s)
1st May 20205:49 pmRNSHolding(s) in Company
30th Apr 202012:01 pmRNSHolding(s) in Company
27th Apr 20206:25 pmRNSArticles of Incorporation re LR 9.2.6ER(1)
6th Apr 20204:43 pmRNSSecond Price Monitoring Extn
6th Apr 20204:37 pmRNSPrice Monitoring Extension
2nd Apr 20209:00 amRNSDirector/PDMR Shareholding
27th Mar 202011:08 amRNSNet Asset Value(s)
23rd Mar 20204:07 pmRNSPortfolio Update
20th Mar 20201:12 pmRNSResult of EGM and Change of Name
17th Mar 20203:33 pmRNSHolding(s) in Company
5th Mar 20209:08 amRNSPublication of Circular and Notice of EGM
28th Feb 20207:00 amRNSNet Asset Value(s)
19th Feb 20203:30 pmRNSTermination of Investment Advisory Agreement
13th Feb 20208:25 amRNSHolding(s) in Company
11th Feb 20201:57 pmRNSCompany Update - Replacement
11th Feb 202012:08 pmRNSSecond Price Monitoring Extn
11th Feb 202012:03 pmRNSPrice Monitoring Extension
10th Feb 202012:40 pmRNSPortfolio Update
10th Feb 202012:35 pmRNSCompany Update
10th Feb 202012:30 pmRNSNet Asset Value(s)
7th Feb 20204:01 pmRNSDividend Declaration
5th Feb 20205:10 pmRNSHolding(s) in Company
5th Feb 202010:18 amRNSHolding(s) in Company
31st Jan 20205:01 pmRNSHolding(s) in Company
31st Jan 202012:19 pmRNSHolding(s) in Company
30th Jan 202011:26 amRNSHolding(s) in Company
2nd Jan 20207:00 amRNSNet Asset Value(s)
17th Dec 20195:02 pmRNSNet Asset Value and Company Update
9th Dec 20194:44 pmRNSDirectorate Changes
9th Dec 20194:41 pmRNSResult of AGM
9th Dec 20198:00 amRNSCompany Update
20th Nov 20196:13 pmRNSHolding(s) in Company
20th Nov 20197:00 amRNSPortfolio Update
8th Nov 201910:53 amRNSHolding(s) in Company
31st Oct 201912:28 pmRNSHolding(s) in Company
29th Oct 201911:32 amRNSHolding(s) in Company
25th Oct 201910:00 amRNSPortfolio Update
25th Oct 20199:45 amRNSNet Asset Value(s)
25th Oct 20197:00 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20196:05 pmRNSHolding(s) in Company
24th Oct 20195:30 pmRNSDividend Declaration
4th Oct 201912:20 pmRNSNet Asset Value(s)
2nd Oct 20197:00 amRNSPortfolio Update
1st Oct 20198:00 amRNSTotal Voting Rights
10th Sep 201911:26 amRNSHolding(s) in Company
10th Sep 201911:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.